Linked Data API

Show Search Form

Search Results

1177641
registered interest false more like this
date less than 2020-02-11more like thismore than 2020-02-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking improve cancer treatment in the (a) Epsom and St Helier University Hospitals NHS Trust and (b) Royal Marsden NHS Trust. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Elliot Colburn more like this
uin 625 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-19more like thismore than 2020-02-19
answer text <p>Epsom and St Helier University Hospitals NHS Trust has a strong track record of providing high quality care to people with suspected or confirmed cases of cancer in a timely manner. Last year, the Trust met all of the waiting time standards we expect for cancer patients, including seeing 97.2% of patients with a suspected cancer within two weeks of their general practitioners (GPs) referral, 99.1% of patients began treatment with 31 days of diagnosis, and 89% of patients began treatment within 62 days of their initial referral.</p><p>Epsom and St Helier University Hospitals NHS Trust is working on plans to improve the patient’s experience through their cancer journey. This includes access to a clinical nurse specialist or key worker, and they have recently appointed three Advanced Nurse Practitioners and funding approved to increase number of clinical nurse specialists. The Trust is introducing ‘Living With and Beyond Cancer’ – a new work stream to improve patient experience and care beyond their diagnosis and initial treatment and improving quality of life for those living with cancer. This includes NHS England and NHS Improvement data collection on long term quality of life metrics, stratified follow up pathways, reducing and managing long term outcomes of treatment, and Holistic Needs Assessments.</p><p>The Royal Marsden NHS Foundation Trust is a research active organisation, with an academic partnership with The Institute of Cancer Research, and, together, are ranked third in the world for impact of their research. The Royal Marsden is continually looking to improve the treatment options and facilities they offer to patients, including the first linear accelerators (LINAC) in the country and third in the world, which is now treating patients across six tumour types as part of clinical trials.</p><p>The Royal Marsden is also the host of RM Partners, the only cancer alliance in England to achieve the 62 day target consistently during 2018/19 and which was awarded a further £10 million in funding from NHS England to continue to improve cancer outcomes for the population across west London.</p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 626 more like this
question first answered
less than 2020-02-19T12:09:04.51Zmore like thismore than 2020-02-19T12:09:04.51Z
answering member
4380
label Biography information for Jo Churchill remove filter
tabling member
4775
label Biography information for Elliot Colburn more like this
1177642
registered interest false more like this
date less than 2020-02-11more like thismore than 2020-02-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of cancer treatment outcomes in the (a) Epsom and St Helier University Hospitals and (b) Royal Marsden NHS Trusts. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Elliot Colburn more like this
uin 626 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-19more like thismore than 2020-02-19
answer text <p>Epsom and St Helier University Hospitals NHS Trust has a strong track record of providing high quality care to people with suspected or confirmed cases of cancer in a timely manner. Last year, the Trust met all of the waiting time standards we expect for cancer patients, including seeing 97.2% of patients with a suspected cancer within two weeks of their general practitioners (GPs) referral, 99.1% of patients began treatment with 31 days of diagnosis, and 89% of patients began treatment within 62 days of their initial referral.</p><p>Epsom and St Helier University Hospitals NHS Trust is working on plans to improve the patient’s experience through their cancer journey. This includes access to a clinical nurse specialist or key worker, and they have recently appointed three Advanced Nurse Practitioners and funding approved to increase number of clinical nurse specialists. The Trust is introducing ‘Living With and Beyond Cancer’ – a new work stream to improve patient experience and care beyond their diagnosis and initial treatment and improving quality of life for those living with cancer. This includes NHS England and NHS Improvement data collection on long term quality of life metrics, stratified follow up pathways, reducing and managing long term outcomes of treatment, and Holistic Needs Assessments.</p><p>The Royal Marsden NHS Foundation Trust is a research active organisation, with an academic partnership with The Institute of Cancer Research, and, together, are ranked third in the world for impact of their research. The Royal Marsden is continually looking to improve the treatment options and facilities they offer to patients, including the first linear accelerators (LINAC) in the country and third in the world, which is now treating patients across six tumour types as part of clinical trials.</p><p>The Royal Marsden is also the host of RM Partners, the only cancer alliance in England to achieve the 62 day target consistently during 2018/19 and which was awarded a further £10 million in funding from NHS England to continue to improve cancer outcomes for the population across west London.</p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 625 more like this
question first answered
less than 2020-02-19T12:09:04.573Zmore like thismore than 2020-02-19T12:09:04.573Z
answering member
4380
label Biography information for Jo Churchill remove filter
tabling member
4775
label Biography information for Elliot Colburn more like this
1177652
registered interest false more like this
date less than 2020-02-11more like thismore than 2020-02-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Genito-urinary Medicine more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when his Department plans to publish its national sexual health and reproductive health strategy. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Elliot Colburn more like this
uin 634 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-19more like thismore than 2020-02-19
answer text <p>Work on the development of a new national sexual and reproductive health strategy is underway with the Department working with Public Health England, NHS England and Improvement, local government and other partners. Some initial engagement with stakeholders has already taken place and we are also considering the responses to the Green Paper ‘Advancing our Health’ and the suggestions for priority areas for the new strategy we received through the consultation process. Details of the strategy’s scope, plans for more formal engagement with external organisations, including roundtables, timing of publication and implementation will be announced in due course.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 635 more like this
question first answered
less than 2020-02-19T12:18:15.853Zmore like thismore than 2020-02-19T12:18:15.853Z
answering member
4380
label Biography information for Jo Churchill remove filter
tabling member
4775
label Biography information for Elliot Colburn more like this
1177653
registered interest false more like this
date less than 2020-02-11more like thismore than 2020-02-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Genito-urinary Medicine more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when his Department plans to hold its stakeholder roundtable events on the national sexual health and reproductive health strategy. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Elliot Colburn more like this
uin 635 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-19more like thismore than 2020-02-19
answer text <p>Work on the development of a new national sexual and reproductive health strategy is underway with the Department working with Public Health England, NHS England and Improvement, local government and other partners. Some initial engagement with stakeholders has already taken place and we are also considering the responses to the Green Paper ‘Advancing our Health’ and the suggestions for priority areas for the new strategy we received through the consultation process. Details of the strategy’s scope, plans for more formal engagement with external organisations, including roundtables, timing of publication and implementation will be announced in due course.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 634 more like this
question first answered
less than 2020-02-19T12:18:15.92Zmore like thismore than 2020-02-19T12:18:15.92Z
answering member
4380
label Biography information for Jo Churchill remove filter
tabling member
4775
label Biography information for Elliot Colburn more like this
1177654
registered interest false more like this
date less than 2020-02-11more like thismore than 2020-02-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading HIV Infection: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure access for all to PrEP prior to routine commissioning starting in April 2020. more like this
tabling member constituency Carshalton and Wallington remove filter
tabling member printed
Elliot Colburn more like this
uin 636 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-19more like thismore than 2020-02-19
answer text <p>Anyone requesting pre-exposure prophylaxis (PrEP) through the Impact Trial must meet the agreed eligibility criteria. A core function of the trial’s Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following link:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p>The Impact Trial website includes a map showing the distribution of the 154 clinics level 3 Sexual Health Services participating in the trial at the following link:</p><p><a href="http://www.prepimpacttrial.org.uk" target="_blank">www.prepimpacttrial.org.uk</a></p><p>The Department is continuing to work closely with NHS England and NHS Improvement, Public Health England and local authorities to plan for routine commissioning of PrEP from April 2020. NHS England and NHS Improvement have already agreed to fund the on-going costs of drugs for PrEP going forward. We will provide information on how other elements of the programme will be funded and how commissioners will be supported very shortly.</p><p> </p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 637 more like this
question first answered
less than 2020-02-19T12:17:30.607Zmore like thismore than 2020-02-19T12:17:30.607Z
answering member
4380
label Biography information for Jo Churchill remove filter
tabling member
4775
label Biography information for Elliot Colburn more like this